Author

Vineeth Varanasi

Observed names: Varanasi Vineeth, Varanasi, Vineeth

Institutions: University of Chicago, Novartis (India)

Observed institutions: Regional Medical Research Center, University of Chicago, Novartis (India), Bharat Biotech (India), National Institute of Immunology

ORCID: 0000-0002-6542-5777

Observed ORCID: 0000-0002-6542-5777

OpenAlex ID: A5060775744

Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study

2015 · Vadrevu Krishna Mohan, Vineeth Varanasi, et al. · Clinical Infectious Diseases · 201

PDF

Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses

2004 · Anita Mangla, Anupriya Khare, et al. · Blood · 128

PDF

Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials

2023 · Marcus Maurer, Luis Felipe Ensina, et al. · The Lancet · 73

NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses

2012 · Andrew Zloza, Frederick J Kohlhapp, et al. · Nature Medicine · 66

Development of a real-time polymerase chain reaction assay for the quantification of Leishmania species and the monitoring of systemic distribution of the pathogen

2008 · Nitin Tupperwar, Varanasi Vineeth, et al. · Diagnostic Microbiology and Infectious Disease · 55

Cytotoxic Mechanisms Employed by Mouse T Cells to Destroy Pancreatic β-Cells

2012 · Vineeth Varanasi, Lia Avanesyan, et al. · Diabetes · 39

PDF

Loss of the death receptor CD95 (Fas) expression by dendritic cells protects from a chronic viral infection

2014 · Vineeth Varanasi, Aly Azeem Khan, et al. · Proceedings of the National Academy of Sciences · 13

Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria: Results from the Phase-3 Pivotal Trials

2023 · Luis Felipe Ensina, Jonathan Bernstein, et al. · Journal of Allergy and Clinical Immunology · 7

Mediation of transitional B cell maturation in the absence of functional Bruton’s tyrosine kinase

2017 · Shalini Tanwar, Atika Dhar, et al. · Scientific Reports · 7

PDF

Long term safety and efficacy of ligelizumab in the treatment of Japanese patients with chronic spontaneous urticaria

2024 · Hidetoshi Takahashi, Atsushi Fukunaga, et al. · Allergology International · 2

A Superantigen Interacts with Leishmanial Infection in Antigen‐Presenting Cells to Regulate Cytokine Commitment of Responding CD4 T Cells

2010 · Vineeth Varanasi, Hamid Mattoo, et al. · The Journal of Infectious Diseases · 2

Defining a ‘valid’ measurement and test-retest reliability of actigraphy based digital endpoints of physical activity in knee osteoarthritis

2024 · William Johnston, Michael Scharfe, et al. · Osteoarthritis and Cartilage · 1

PDF

OC.56 Safety and early efficacy of rapcabtagene autoleucel, an autologous CD19-directed chimeric antigen receptor T-cell therapy, in severe refractory diffuse cutaneous systemic sclerosis

2026 · Dinesh Khanna, Christopher Denton, et al.

B cells enable autoreactive T cells to avoid suppression

2026 · Matthew Funsten, Renee de Pooter, et al. · Proceedings of the National Academy of Sciences

PDF

Long‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria

2025 · Ana M. Gimenez‐Arnau, Marcus Maurer, et al. · Allergy

PDF

Ligelizumab use for chronic spontaneous urticaria – Authors' reply

2025 · Ana M Giménez-Arnau, Manmath Patekar, et al. · The Lancet

PDF

Regulation of immune inflammation networks

2007 · Vineeth Varanasi · INFLIBNET

Works count: 19

Citation count: 595

H-index: 7

I10-index: 7